| Typicality: | 0.215 |
| Saliency: | 0.125 |
| for up to six months | 2 | temporal |
| compared to placebo | 2 | other |
| in boys with dmd | 2 | other |
| corticosteroid → improve → muscle strength | 5 |
| negative | neutral | positive |
| 0.005 | 0.332 | 0.663 |
| Raw frequency | 5 |
| Normalized frequency | 0.125 |
| Modifier score | 0.500 |
| Perplexity | 25.067 |